Vascular smooth muscle cells (SMCs) have been implicated in the pathophysiology of stroke, the third most common cause of death and the leading cause of long-term neurological disability in the world. However, there is little insight into the underlying cellular pathways that link SMC function to brain ischemia susceptibility. Using a hitherto uncharacterized knockout mouse model of Notch 3, a Notch signaling receptor paralogue highly expressed in vascular SMCs, we uncover a striking susceptibility to ischemic stroke upon challenge. Cellular and molecular analyses of vascular SMCs derived from these animals associate Notch 3 activity to the expression of specific gene targets, whereas genetic rescue experiments unambiguously link Notch 3 function in vessels to the ischemic phenotype.
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ischemia ͉ Notch3 ͉ vascular smooth muscle ͉ CADASIL N otch signaling defines one of the fundamental cell interaction mechanisms governing cell fate choices in metazoans (1, 2) . The central element of this signaling pathway is the Notch cell surface receptor, a single-pass transmembrane protein, which interacts with membrane-bound ligands expressed on adjacent cells linking the fate of one cell to that of its neighbor (3, 4) . In mammals, four paralogs of the Notch receptor have been identified, Notch 1-4, with overlapping but nonidentical expression patterns (5) . In adult tissues, Notch 3 expression is restricted to vascular smooth muscle cells (SMCs) (5) . Notwithstanding subtle arterial abnormalities reported in Notch 3 mutant mice (6) , the role of Notch 3 in vascular physiology remains unclear.
Results
To explore Notch 3 function, we used a previously uncharacterized Notch 3 knockout mouse model provided by W. C. Skarnes and M. Tessier-Lavigne (7) . Like Notch 3 knockouts studied in refs. 8 and 9, this mutant mouse was viable and fertile. The null allele was generated by insertional mutagenesis with a lacZ carrying vector so that ␤-galactosidase (␤-gal) expression parallels that of Notch 3 (Fig. 1) . Our analysis generally agrees with reported Notch 3 expression studies in the vasculature (10) but did reveal a broader distribution, including the neuronal progenitor-containing ventricular zone of the developing neural tube between embryonic day 12.5 (E12.5) and E15.5 and the neonatal brain [supporting information (SI) Appendix, SI Fig. 6 , and data not shown]. Relevant to this study, in situ hybridization, X-gal staining, and immunofluorescence confirmed expression of Notch 3 in SMCs from brain vessels and aorta ( Fig. 1 D-F and data not shown). A morphological study involving immunostaining with SMC-specific antibodies and electron microscopy did not reveal any abnormalities in either brain vessels or the aorta of knockout mice ( Fig. 1G ; SI Appendix, SI Fig. 7 ; and data not shown).
To investigate further the properties of SMCs lacking Notch 3 function, we developed a FACS-based cell purification protocol, taking advantage of the ␤-gal expression associated with the Notch 3 knockout allele in SMCs, virtually the only cells in the adult brain to express Notch 3 ( Figs. 1 and 2 ). Brain-derived cells from Notch 3 ϩ/Ϫ or Notch 3 Ϫ/Ϫ mice were isolated and shown to express ␤-gal and specific markers confirming SMC identity ( Fig.  2 B and C and SI Appendix, SI Fig. 8 ). Availability of a highly enriched population of SMCs allowed us to examine the impact of Notch 3 loss-of-function on the transcriptional profile of brain-derived SMCs (BrSMCs). Comparative analysis between Notch 3 ϩ/Ϫ and Notch 3 Ϫ/Ϫ cells revealed 662 differentially regulated genes, using an arbitrary cutoff (P Յ 0.01, fold change Ϯ 1.5). Notch 3 scores as the utmost down-regulated gene (Ϫ22.1-fold) in Notch 3 Ϫ/Ϫ BrSMCs. Indicative of their abnormal Notch signaling capacity, the canonical Notch downstream targets Heyl and Hes1 were down-regulated (both Ϫ1.5-fold).
Gene ontology analysis of all misregulated targets in BrSMCs showed statistical overrepresentation of genes classified under four functional categories named ''muscle contraction'' (all down-regulated), ''cell structure and motility,'' ''muscle development,'' and ''mesoderm development'' (SI Appendix, SI Tables  1 and 2) , consistent with the notion that SMCs from knockout animals harbor significant functional differences compared with those carrying WT Notch 3 receptors.
Given the relevance of vascular SMCs to stroke, we examined the ischemia susceptibility of mice lacking Notch 3 function in a standard filament model of proximal middle cerebral artery (MCA) occlusion (11) . In this assay, Notch 3 Ϫ/Ϫ mice developed ischemic lesions approximately twice as large as those seen in WT or heterozygous (Notch 3 ϩ/Ϫ ) 10-to 12-week-old male mice ( Fig. 3 A and B) . Consistent with the severity of stroke, neurological deficits were more pronounced (Bederson neurological score on day 1 median values: WT ϭ 1, Notch 3 Ϫ/Ϫ ϭ 2, P Ͻ 0.01) and mortality higher upon MCA occlusion in Notch 3 Ϫ/Ϫ mice compared with WT (Fig. 3C ). To assess whether enlarged infarcts were the result of more severe cerebral blood flow (CBF) deficits, we used laser speckle flowmetry (LSF) during distal MCA occlusion (12) . This two-dimensional optical imaging technique measures cortical blood flow with high spatial resolution, quantifies the ischemic area, and allows for monitoring of spontaneous periinfarct depolarizations (PIDs) triggered by anoxic release of K ϩ and excitatory amino acids from the infarct core (13, 14) . Using this method, we found that Notch 3 Ϫ/Ϫ mice developed a 60% larger area of severe CBF deficit than WT mice (P Ͻ 0.01) (Fig. 3 D and E) . Thus, using two distinct approaches, we find complete loss of Notch 3 function to be associated with significant ischemic abnormalities. Interestingly, the frequency of spontaneous PIDs, which are known to aggravate stroke (15), was more than doubled in Notch 3 Ϫ/Ϫ compared with WT mice (6.0 Ϯ 2.5 vs. 2.9 Ϯ 2.5 PIDs per h, P Ͻ 0.05) (Fig. 4) . However, Notch 3 Ϫ/Ϫ mice did not exhibit the characteristic transient hypoperfusion episodes during PIDs, suggesting that the vasoconstrictive ability of cerebral vessels was impaired in the mutants, an observation congruent with the down-regulation of muscle contraction genes unveiled by microarray analysis (Fig.  4) . Systemic physiological variables (SI Appendix, SI Table 3 ) and absolute resting CBF (134 Ϯ 45 ml⅐100 g
in WT) and circle of Willis anatomy, examined by carbon black perfusion for the presence of communicating arteries (SI Appendix, SI Fig. 9 ), did not reveal any differences between WT and Notch 3 Ϫ/Ϫ mice that would explain the ischemic susceptibility.
To link unambiguously the ischemic phenotype with Notch 3 function, we deemed it essential to examine whether expression of WT Notch 3 in the SMCs could rescue the Notch 3 Ϫ/Ϫ ischemic phenotype. To that end, we generated a conditional transgenic mouse, ROSA NOTCH 3, which, when crossed to an appropriate Cre line [SM22-Cre (16)] could sustain SMC-specific expression of a human NOTCH 3 transgene (Fig. 5) . We found that expression of WT NOTCH 3 in vascular SMCs of knockout mice reduced infarct volume after filament occlusion of MCA ( Fig. 5 E and F). Thus, Notch 3 expression in SMCs is both necessary and sufficient to rescue stroke susceptibility in knockout mice, directly linking the ischemic phenotype with Notch 3 function in SMCs.
Discussion
Stroke burden is a key factor in determining short-and long-term neurological disability. Although not completely understood, extensive studies indicate that stroke burden varies greatly depending on complex interactions between blood vessels and brain cells (17) . Here, we clearly link Notch signaling to ischemic stroke and raise the possibility that Notch 3 defines a key determinant of stroke burden through regulation of vascular SMC function.
Extensive functional studies of contractile activity in isolated aortas did not reveal differences between Notch 3 knockout and WT animals (SI Appendix, SI Fig. 10 ). In contrast, abnormalities in contractile tone in cerebral vessels are suggested by the lack of vasoconstrictive response to PIDs during ischemia in Notch 3 Ϫ/Ϫ animals. Consistent with these data, the microarray analysis links Notch 3 expression in SMCs from cerebral arteries with genes involved in vascular tone (SI Appendix, SI Tables 1 and 2) , whereas no such link could be established when SMCs from aortas were used (data not shown). Whether the differences between brain and aorta SMCs revealed by these studies reflect genuine molecular phenotypic characteristics and distinct physiological properties remains to be determined.
The relevance of this study to human stroke is exemplified by the fact that NOTCH 3 mutations, of obscure functional nature, are the only known cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a paradigmatic neurological disease characterized by vascular SMC pathology, progressive brain ischemia, and vascular cognitive impairment (18, 19) . Although vascular abnormalities in CADASIL are widespread, anatomical studies have shown a predilection of NOTCH 3-associated pathology for small vessels particularly in those brain regions with lowest blood flow values, such as the white matter (20) .
The availability of appropriate mouse models to study the role of Notch 3 in brain ischemia is of significance because CADASIL is a prevalent cause of stroke and vascular cognitive impairment in humans and because such models may prove valuable in increasing our general understanding of the cellular and molecular mechanisms underlying stroke pathophysiology.
Materials and Methods
Animal Protocols. Animal care and experimental procedures were performed with approval from institutional animal care and use committees of Massachusetts General Hospital, Harvard Medical School and Yale University. Littermates were used for comparative analysis throughout.
In Situ Hybridization and Detection of ␤-Galactosidase Activity. Animals were fixed by transcardiac perfusion with 4% paraformaldehyde in PBS. Brains were removed, fixed overnight in 30% sucrose and 4% paraformaldehyde, and sectioned in the coronal plane on a sledge cryomicrotome (Leica SM2000) at 40 m. In situ hybridization was essentially performed as described in refs. 21 and 22. X-gal staining was performed overnight at 30°C in a solution containing 0.5 mM potassium ferricyanide, 0.5 mM potassium ferrocyanide, 20 mM MgCl2, 0.1% Triton X-100, and 0.37 mg/ml X-gal.
Purification of Brain-Derived SMCs.
Ten-to 12-week-old male mice were killed and perfused with 10 ml of PBS before brain dissection. After removal of the meninges, brain tissues were fragmented with a razor blade and digested in 10 ml of PBS (without calcium or magnesium) supplemented with a collagenase/dispase mixture (100 g/ml, Roche), incubated for 75 min at 37°C, and homogenized by using a 10-ml pipette. Undigested material was removed by using a 100-m cell strainer. The flow-through was centrifuged at 4°C for 3 min at 834 ϫ g and the pellet washed with 10 ml of PBS (with calcium and magnesium) four times. Cells were resuspended in Opti-MEM (without phenol red; Invitrogen) before staining with fluorescein di-␤-D-galactopyranoside (FDG), a fluorogenic substrate for ␤-gal (Fluka), using standard methodology (23) modified as follows: FDG stock was prepared in a H2O:Ethyl:DMSO (8:1:1) solution to a final concentration of 30 mM and kept frozen at Ϫ20°C. For staining, 2 mM FDG (in 100 l of H2O) and cells (in 100 l of medium; 1 ϫ 10 7 cells per ml) were preincubated for 5 min at 37°C, mixed together, and then incubated for 1 min at 37°C to induce FDG uptake. The reaction was stopped by adding 0.8 ml of Opti-MEM and incubation on ice. Individual cell preparations were finally pooled, centrifuged 3 min, and resuspended in Opti-MEM (at concentrations 2-10 ϫ 10 6 cells per ml) before FACS analysis and sorting. In ␤-gal positive cells, FDG is metabolized to fluorescein allowing FACS sorting and culture of brain-derived SMCs. This method typically yields 7.5 ϫ 10 4 to 1 ϫ 10 5 fluorescein-positive cells per adult mouse brain. These were routinely kept for 1-7 days in culture (F12/MEM and 10% FBS; Invitrogen) or fixed with 4% paraformaldehyde before immunofluorescence studies. Purity of the SMC preparations was determined by using X-gal staining, and antibodies specific for Notch 3 and ␣-smooth muscle actin (see SI Appendix), thus they may also contain pericytes.
Microarray Studies. Biotinylated cRNA samples from freshly sorted brain SMCs (four Notch 3 ϩ/Ϫ mice and five Notch 3 Ϫ/Ϫ mice) were fragmented before hybridization (15 g each) onto mouse 430 2.0 Affymetrix chips. The chips were washed, stained by using strepavidin-phycoerytrin, and scanned the next day as described in ref. 24 . For data normalization, all probe sets were scaled to a target intensity of 150. Microarray data analysis was performed by using Rosetta Resolver. All cells were from 10-to 12-week-old male mice. Gene Ontology Analyses. PANTHER software was used to define over-and underrepresented functions in the list of signature genes found by microarray analysis (25) . P values were calculated by using binomial statistics.
Model of Focal Cerebral Ischemia. Animals were anesthetized with 2% isoflurane and maintained on 1.5% isoflurane in 70% N 2O and 30% O2 by a face mask. Cerebral infarcts were produced by 1 h of MCA occlusion followed by reperfusion as described in refs. 11, 26, and 27. Regional CBF and physiologic parameters were monitored as described in refs. 11, 26, and 27. Infarct volumes were calculated by integrating the infarct area in each brain section of the brain, using the indirect method to correct for edema.
Determination of Infarct Size. After kill, cerebral infarct sizes were determined on 2,3,5-triphenyltetrazolium chloride (TTC, 22 h)-stained 2-mm brain sections by means of an image analysis system (M4; Imaging Research) as described in refs. 11, 26, and 27.
Neurological Evaluation. Mice that underwent 1 h of fMCAO were evaluated for neurological deficits over a period of 1 week. Deficits were measured on a well established five-point neurological scale (28): 0, no neurologic deficit; 1, failure to extend the left forepaw fully; 2, circling to the left; 3, falling or leaning over to the left; 4, no spontaneous walking and a depressed level of consciousness; or 5, dead. All animals tested had a score of 0 before undergoing fMCAO.
Laser Speckle Flowmetry (LSF). Adult mice were anesthetized with isoflurane (2% induction, 1% maintenance), endothracheally intubated, and ventilated. Blood pressure and heart rate were continuously recorded by using PowerLab (ADInstruments). Physiological monitoring (blood pressure, arterial blood gases, and pH) was performed at least once every hour, and the adequacy of anesthesia was regularly checked by the absence of a blood pressure response to tail pinch. After general surgical preparation, mice were placed in a stereotaxic frame, and skull surface was prepared for LSF to study the spatiotemporal characteristics of cerebral blood flow (CBF) changes during focal ischemia. Focal ischemia was induced by clipping the MCA and LSF imaging was initiated 1 min before MCA ligation and continued up to 90 min. Images obtained by a CCD camera positioned above the head were analyzed by using three separate paradigms to determine the time course of CBF changes, the area of severe, moderate or mildly ischemic cortex, and the CBF profile between the nonischemic cortex and the ischemic core (12) .
Generation of ROSA NOTCH 3 Mice. We generated a conditional knockin mouse to determine tissue-specific requirements for Notch 3 expression. For this purpose, the human NOTCH 3 cDNA generously provided to us by E. TournierLasserve (Institut National de la Santé , et de la Recherche Mé dicale U740, Paris, France) was subcloned into a vector designed for site-specific recombination into the ubiquitously expressed ROSA26 mouse locus (29) . In the final construct, NOTCH 3 was flanked by a loxed stop cassette at the 5Јend (for Cre-mediated regulation of expression) and an IRES-nuclearGFP sequence at the 3Ј end. The resulting construct was sequenced and electroporated into ES cells (129SV/J line) before selection of positive clones by long-range PCR and Southern blot hybridization. Chimeras generated through embryo injections of ES cells clones were crossed to C57BL/6 mice to obtain germ-line transmission. The resulting ROSA NOTCH 3 knockin mice (WT76 line) were viable and fertile and displayed no gross abnormalities. 
